Provectus Biopharmaceuticals, Inc. requests that their press release NewsItemId: 20170103005154 entitled “Provectus Biopharmaceuticals Will Hold a Business Update Conference Call Thursday – January 5, 2017 at 9 a.m. (EST)” be killed.
The conference call cited in the press release is no longer scheduled to take place.
Provectus Biopharmaceuticals, Inc.
Timothy C. Scott, Ph.D., 866-594-5999
Porter, LeVay & Rose, Inc.
Marlon Nurse, 212-564-4700
DM, SVP – Investor Relations
Allison + Partners
Todd Aydelotte, 646-428-0644
Managing Director –Media Relations